OQS
DTIL icon

Occudo Quantitative Strategies’s Precision BioSciences DTIL Stock Holding History

Occudo Quantitative Strategies’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,560
Closed -$52.3K – 787
2025
Q4 		$52.3K Buy
+12,560
New +$71.3K ﹤0.01% 664
2023
Q2 		– Sell
-1,794
Closed -$40.6K – 1075
2023
Q1 		$40.6K Sell
1,794
-488
-21% -$16.1K ﹤0.01% 854
2022
Q4 		$81.5K Sell
2,282
-584
-20% -$23.1K 0.01% 863
2022
Q3 		$112K Hold
2,866
– – 0.01% 1030
2022
Q2 		$138K Sell
2,866
-256
-8% -$15K 0.01% 971
2022
Q1 		$289K Buy
+3,122
New +$424K 0.02% 831

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Occudo Quantitative Strategies's DTIL Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Precision BioSciences (DTIL) in Q1 2026, closing a stake of 12,560 shares — an estimated $52.3K sold.

Occudo Quantitative Strategies first reported a position in DTIL in Q1 2022 and held it in 6 quarters. The position peaked at $289K in Q1 2022. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Occudo Quantitative Strategies reported no remaining Precision BioSciences position as of Q1 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 12,560 Precision BioSciences shares in Q1 2026, an estimated $52.3K.
  • Occudo Quantitative Strategies first reported a position in Precision BioSciences in Q1 2022 and held it in 6 quarters.
  • Occudo Quantitative Strategies's Precision BioSciences position peaked at $289K in Q1 2022.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.